| The sweet-side of leukocytes: galectins as master regulators of neutrophil function BS Robinson, CM Arthur, B Evavold, E Roback, NA Kamili, CS Stowell, ... Frontiers in immunology 10, 1762, 2019 | 50 | 2019 |
| Soluble ECM promotes organotypic formation in lung alveolar model JC Valdoz, NA Franks, CG Cribbs, DJ Jacobs, EL Dodson, CJ Knight, ... Biomaterials 283, 121464, 2022 | 25 | 2022 |
| Treatment with galectin-1 improves myogenic potential and membrane repair in dysferlin-deficient models PMVR Mary L. Vallecillo-Zúniga,Matthew F. Rathgeber,P. Daniel Poulson ... PLOS, 2020 | 22* | 2020 |
| Prior Immunization to an Intracellular Antigen Enhances Subsequent Red Blood Cell Alloimmunization in Mice RP Jajosky, SR Patel, SC Wu, KR Patel, ML Covington, ... Blood, 2023 | 18* | 2023 |
| De novo design of highly selective miniprotein inhibitors of integrins αvβ6 and αvβ8 A Roy, L Shi, A Chang, X Dong, A Fernandez, JC Kraft, J Li, VQ Le, ... Nature Communications 14 (1), 5660, 2023 | 16 | 2023 |
| The sweet-side of leukocytes: galectins as master regulators of neutrophil function. Front Immunol 10: 1762 BS Robinson, CM Arthur, B Evavold, E Roback, NA Kamili, CS Stowell, ... | 8 | 2019 |
| Whole microbe arrays accurately predict interactions and overall antimicrobial activity of galectin-8 toward distinct strains of Streptococcus pneumoniae SC Wu, ML Jan, Hau-Ming, Vallecillo-Zúniga, MF Rathgeber, CS Stowell, ... Scientific Reports 13 (5324), https://rdcu.be/c83Hi, 2023 | 7 | 2023 |
| Galectin-4 Antimicrobial Activity Primarily Occurs Through its C-Terminal Domain HM Jan, SC Wu, CJ Stowell, ML Vallecillo-Zúniga, A Paul, KR Patel, ... Molecular & Cellular Proteomics 23 (5), 2024 | 6 | 2024 |
| Therapeutic Benefit of Galectin-1: Beyond Membrane Repair, a Multifaceted Approach to LGMD2B ML Vallecillo-Zúniga Cells 10 (11), 3210, 2021 | 3 | 2021 |
| Evaluating Therapeutic Activity of Galectin-1 in Sarcolemma Repair of Skeletal Muscle ML Vallecillo-Zúniga, M Rathgeber, D Poulson, B Kartchner, J Luddington, ... Methods in Molecular Biology. 2442, 663-683, 2022 | 1 | 2022 |
| Galectin-1 immunomodulation and myogenic improvements in muscle diseases and autoimmune disorders P Van Ry, M Vallecillo US Patent App. 18/281,927, 2024 | | 2024 |
| Galectin-4 antimicrobial activity primarily occurs through its C-terminal domain HM Jan, SC Wu, CJ Stowell, ML Vallecillo-Zuniga, A Paul, KR Patel, ... GLYCOBIOLOGY 33 (11), 968-969, 2023 | | 2023 |
| Galectin-1 immunomodulation and myogenic improvements in muscle diseases and autoimmuine disorders P Van Ry, M Vallecillo US Patent App. 17/995,794, 2023 | | 2023 |
| Inhaled Therapeutic for Idiopathic Pulmonary Fibrosis Reduces Fibrotic Biomarkers in Mouse Model A Chang, A Roy, L , Shi, R Viazzo Winegar, D , Slocum, D Poulson, ... American Thoracic Society International Conference, 2023 | | 2023 |
| Ensayos clínicos en Honduras: consideraciones éticas J Solano, O Garner, J García, ML Vallecillo-Zúniga Innovare: Revista de ciencia y tecnología 11 (3), 190-192, 2022 | | 2022 |
| Clinical trials in Honduras: ethical considerations J Solano, O Garner, J García, ML Vallecillo-Zúniga INNOVARE CIENCIA Y TECNOLOGÍA 11 (3), 190-192, 2022 | | 2022 |
| Vascular lung triculture organoid via soluble extracellular matrix suspension JC Valdoz, NA Franks, CG Cribbs, DJ Jacobs, EL Dodson, CJ Knight, ... | | 2022 |
| Galectin-1: Development of a Novel Protein Therapy for LGMD2B ML Vallecillo Munguía Brigham Young University. Vallecillo Munguia, Mary Lorena, "Galectin-1 …, 2021 | | 2021 |
| Galectin-1 immunomodulation and myogenic improvements in muscle diseases and autoimmune disorders P Van Ry, M Vallecillo US Patent App. 17/224,493, 2021 | | 2021 |
| TREATMENT WITH GALECTIN-1 IMPROVES MYOGENESIS AND MEMBRANE REPAIR IN DYSFERLIN-DEFICIENT MODELS. ML Vallecillo-Zúniga, M Rathgeber, D Poulson, B Kartchner, J Luddington, ... Muscular Dystrophy Association, 2021 | | 2021 |
